Multiple endocrine neoplasia type 1

Multiple endocrine neoplasia type 1 (MEN 1) is an autosomal-dominant inherited tumor syndrome characterized by hyperplasia and/or tumors in the parathyroid glands, the pancreatic islets, the anterior pituitary and adrenal glands, as well as neuroendocrine tumors in the thymus, lungs and stomach, and...

Full description

Saved in:
Bibliographic Details
Published inExpert review of endocrinology & metabolism Vol. 4; no. 4; p. 371
Main Authors Lips, Cornelis Jm, Dreijerink, Koen, Links, Thera P, Höppener, Jo Wm
Format Journal Article
LanguageEnglish
Published England 01.07.2009
Subjects
multiple endocrine neoplasia type 1
menin
genetic testing
mutation analysis
presymptomatic treatment
MEN 1
periodic clinical monitoring
DNA diagnosis
Online AccessGet more information

Cover

More Information
Summary:Multiple endocrine neoplasia type 1 (MEN 1) is an autosomal-dominant inherited tumor syndrome characterized by hyperplasia and/or tumors in the parathyroid glands, the pancreatic islets, the anterior pituitary and adrenal glands, as well as neuroendocrine tumors in the thymus, lungs and stomach, and tumors in nonendocrine tissues. In 1997, the responsible MEN1 gene was identified as a tumor-suppressor gene and its product was named menin. In this review, guidelines for early diagnosis, including MEN1 gene mutation analysis, and treatment, including periodic clinical monitoring, have been formulated, enabling improvement of life expectancy and quality of life. Identification of menin-interacting proteins has provided new insights into the function of menin, notably involving regulation of gene transcription related to proliferation and apoptosis, genome stability and DNA repair, and endocrine/metabolic homeostasis. In the near future, target-directed intervention may prevent or delay the onset of MEN 1-related tumors.
ISSN:1744-8417